YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  
  • Tsetse Genome
  • Virome
  • EyeWire Banner
  • 23 and Me
  • Toumazou
  • DeepGenomics
Can the New Google Have a Long and Productive Life?
| MIT Technology Review | To truly change the world, Google's new holding company will need something that has eluded many previous industrial labs: an effective commercialization strategy. more

A Worthy Sequel: PacBio's New Sequencing System
| Bio-IT World | Pacific Biosciences has released a new genome sequencing instrument, the Sequel — providing the first-in-class whole genome assemblies of its predecessor the RS II, but much faster and at half the cost. But the company's underlying problems, pitching high quality in a price-sensitive market, are not much changed. more

With $55M Neon Wants To Make the Cancer Vaccine Problem Personal
| Xconomy | Neon Therapeutics hopes to harness the body's immune system against the genetic fingerprints of tumors, creating a new kind of cancer vaccine. more

PacBio Announces Sequel Sequencing System
| Bio-IT World | Pacific Biosciences today announced a new nucleic acid sequencing platform. The Sequel System provides higher throughput, more scalability, a reduced footprint and lower sequencing project costs compared to the PacBio RS II System, while maintaining the existing benefits of the company’s SMRT Technology. more

September News and Product Briefs
| Bio-IT World | News and product releases from around the industry, including results from a study on Apple's ResearchKit, and population-scale genome analytics from GENALICE. more

Genomics England announces Congenica as an interpretation partner as it expands industry engagement
| CAMBRIDGE, UK - Sep 30, 2015 - Tom Weaver, CEO of Cambridge-based Congenica is delighted that its technology is reaching patients and says; “One of the aims of Genomics England is to enable NHS patients to gain early benefit from advances in genomics and through participation in the 100,000 Genomes Project we have been able to accelerate development of our Sapientia™ diagnostic platform more

| CAMBRIDGE UK, UK - Sep 29, 2015 - Life Sciences Minister George Freeman MP today announced at the GREAT Healthcare Week at the Milan Expo, that Congenica, a world leading developer of genome-based discovery and diagnostic technologies, has been awarded £300,000 by Innovate UK as part of its ‘Finding value in complex data’ competition more

Affordable large-scale DNA variation studies for every DNA researcher
| HARDERWIJK, THE NETHERLANDS - Sep 24, 2015 - Today, GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite more

CSM to Celebrate Grand Opening of New Malvern Facility
| MALVERN, PA - Sep 17, 2015 - CSM is pleased to announce that it will hold a Grand Opening and Ribbon-Cutting ceremony for its newly constructed facility at 300 Technology Drive in the Great Valley Corporate Center of Malvern, Pennsylvania on Thursday, October 15th from 1 p more

Bio-specimen Grant Program Launched
| MINNEAPOLIS, MN, UNITED STATES - Sep 14, 2015 - DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen ResearchGrant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research more

Genedata at SBI2 will Showcase How Genedata Screener Industrializes HCS
| CAMBRIDGE, MA, UNITED STATES - Sep 14, 2015 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, announced it will be among the presenters at the 2nd Annual Society of Biomolecular Imaging and Informatics (SBI2) Meeting more

Government Incentive Programs to Boost the E-Prescribing Market
| ALBANY, NY - Sep 14, 2015 - E-Prescribing is the system to broadcast information related to prescription among prescriber, dispenser, and pharmacy benefit manager electronically that allows a doctor and nurse to broadcast a new prescription electronically when any error in medication takes place at any stage in pharmacy operations more

Growing Dependence and Popularity of the Computational Biology Market
| ALBANY, NY - Sep 14, 2015 - Computational biology refers to the development of techniques for the collection, manipulation, and use of biological data to make discoveries and predictions more

Certara and Paidion Research Form Partnership Focused on Improving Pediatric Drug Development
| PRINCETON, NJ - Sep 10, 2015 - Certara®, the global biosimulation technology-enabled drug development company, and Paidion Research, Inc more

Former Director of Clinical Pharmacology at CDER Appointed to Certara’s Simcyp Scientific Advisory Board
| PRINCETON, NJ - Aug 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Lawrence J more



For more than a decade, MarkLogic has delivered a powerful, agile, and trusted Enterprise NoSQL database platform that enables organizations to turn all data into valuable and actionable information. Organizations around the world rely on MarkLogic’s enterprise grade technology to power the new generation of information applications. MarkLogic is headquartered in Silicon Valley and has offices throughout the U.S., Europe, Asia, and Australia.
For more information, please visit

Thermo Fisher Scientific

GeneArt™ Platinum Cas9 Nuclease
Maximum efficiency, minimal off-target cleavage

New GeneArt Platinum Cas9 Nuclease is wild type Cas9 in protein format for genome editing with CRISPR-Cas9 technology. Platinum Cas9 protein and guide RNA forms a very stable ribonucleotideprotein (RNP) complex that provides the next level of cleavage efficiency over CRISPR-Cas9 vector and mRNA systems. The Cas9 RNP complex can act immediately after it enters the cell since transcription and translation are not required and is rapidly cleared from the cell, minimizing the chance for off-target cleavage events when compared to vector-based systems. The Cas9 protein is microinjection ready with NLS.

The Cas9 nuclease:

  • Streamlines cell engineering by eliminating transcription and translation in the cell
  • Minimizes off-target cleavage due to rapid clearance from the cell
  • Can achieve >70% cleavage efficiency in most cell lines tested and demonstrates superior efficiency in most cell lines that were not addressable before, such as primary or blood cells

Bio IT World Lead Gen  

Upcoming Industry Events and Webinars

 Upcoming Webinars  

Data Integration in Life Science – Are You Ready? |
Thu, May 1 at 1 pm EST | Sponsored by YarcData  

Ready...Set...Collaborate--Saving Millions with Faster Time to Market |
Thu, May 15 at 11 am EST | Sponsored by Exostar 

Redefining Targeted Sequencing: Complete Coverage of Targeted Regions via an Innovative Massively-Parallel Singleplex PCR Enrichment |

Wed, May 28 at 1 pm EST | Sponsored by Wafergen

Genome-Phenome Analysis |
Wed, June 25 at 1 pm EST  | Sponsored by SimulConsult

Recorded Webinars 

How TGen is Applying High Performance Computing to Accelerate Cancer Research 
Sponsored by Terascala

An Integrated Platform for All Translational Medicine Data: Using Visual Analytics and Tibco Spotfire to Enhance Personalized Medicine and Translational Science  
Sponsored by PerkinElmer 

Trends in BioIT Data Management & Storage 
Sponsored by Avere Systems 

Big Bioinformatics and Healthcare Analytics without Big Hassles 
Sponsored by Paradigm4

Manage Complexity by Visual Data Exploration 
Sponsored by Qlucore

Digital Signatures in the Enterprise
Sponsored by ARX 

Complete Webinar Listing 


Upcoming Events 

Bio-IT World Conference & Expo
April 29- May 1, 2014 • Boston, MA

BIOtech 2014 in Japan
May 14-16, 2014  • Tokyo, Japan

2nd Annual Next Generation Sequencing Data Congress
May 19-20, 2014 • London, UK

14th Annual Structure-Based Drug Design
May 21-22, 2014 • Boston, MA

15th Annual Drug Discovery Leaders Summit 2014
June 2-3, 2014 • Geneva, Switzerland

6th Annual Drug Development Congress 2014
June 2-3, 2014 • Geneva, Switzerland

2nd Annual Discovery Chemistry & Drug Design Congress 2014
June 2-3, 2014 • Geneva, Switzerland

Conference on Translational Medicine
September 22-25, 2014 • Vienna, Austria

4th Annual Next Generation Sequencing Asia Congress 2014
October 7-8, 2014 • Singapore

2nd Annual Single Cell Genomics & Transcriptomics Asia Congress 2014
October 7-8, 2014 • Singapore

6th Annual Next Generation Sequencing Congress 2014
November 2014 • UK


Complete Event Listing 

Free Downloads: Whitepapers, Podcasts and More


Related Products

BIOVIA’s ScienceCloud  BIOVIA’s ScienceCloud 

The BIOVIA Biologics Solution  The BIOVIA Biologics Solution 

Making Secure Scientific Collaboration Work

November 13 at 11am EST  |  Register Today to Reserve Your Space Sponsored by    It is no surprise that authors place what they consider to be their most important and promising findings into an abstract. But as an abstract’s size

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.